Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
The Journal of Steroid Biochemistry and Molecular Biology|December 1, 1995
Analysis of the human gene encoding the kidney isozyme of 11 beta-hydroxysteroid dehydrogenaseA K Agarwal, F M Rogerson, T Mune, et al.
The Journal of Clinical Endocrinology and Metabolism|March 1, 1993
Production and secretion of parathyroid hormone-related protein in pheochromocytoma: participation of an alpha-adrenergic mechanismT Mune, H Katakami, Y Kato, et al.
Endocrine Journal|February 1, 1993
Low plasma 19-hydroxyandrostenedione levels in patients with aldosterone-producing adenomaH Morita, T Mune, K Yasuda, et al.
Endocrine Journal|October 1, 1996
Familial isolated hypoparathyroidism: case report with serum PTHrP examinationH Koshiyama, S Mori, T Koh, et al.
Clinical Endocrinology|March 1, 1993
Elevated plasma 19-hydroxyandrostenedione levels in Cushing's disease: stimulation with ACTH and inhibition with metyraponeT Mune, H Morita, K Yasuda, et al.
The Journal of Steroid Biochemistry and Molecular Biology|May 24, 2000
Role of rat adrenal antioxidant defense systems in the aldosterone turn-off phenomenonT Suwa, T Mune, H Morita, et al.
Endocrine Journal|August 25, 1999
Marked increase in plasma ACTH with tumor reduction after chemotherapy in ectopic ACTH syndromeK Yoshino, N Takeda, H Morita, et al.
Nature Genetics|August 1, 1995
Human hypertension caused by mutations in the kidney isozyme of 11 beta-hydroxysteroid dehydrogenaseT Mune, F M Rogerson, H Nikkilä, et al.
Clinical Endocrinology|May 1, 1994
Plasma 18-oxocortisol levels in the patients with adrenocortical disordersN Yamakita, T Mune, H Morita, et al.
Endocrinologia Japonica|August 1, 1992
Beneficial effects of high daily dose bromocriptine treatment in Cushing's diseaseL B Mercado-Asis, K Yasuda, M Murayama, et al.
Pageof 5